BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24411283)

  • 21. Recreational Physical Activity in Relation to Prostate Cancer-specific Mortality Among Men with Nonmetastatic Prostate Cancer.
    Wang Y; Jacobs EJ; Gapstur SM; Maliniak ML; Gansler T; McCullough ML; Stevens VL; Patel AV
    Eur Urol; 2017 Dec; 72(6):931-939. PubMed ID: 28711382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalizability of associations from prostate cancer genome-wide association studies in multiple populations.
    Waters KM; Le Marchand L; Kolonel LN; Monroe KR; Stram DO; Henderson BE; Haiman CA
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1285-9. PubMed ID: 19318432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MSMB gene variant alters the association between prostate cancer and number of sexual partners.
    Stott-Miller M; Wright JL; Stanford JL
    Prostate; 2013 Dec; 73(16):1803-9. PubMed ID: 24037734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased curative treatment is associated with decreased prostate cancer-specific and overall mortality in senior adults with high-risk prostate cancer; results from a national registry-based cohort study.
    Aas K; Dorothea Fosså S; Åge Myklebust T; Møller B; Kvåle R; Vlatkovic L; Berge V
    Cancer Med; 2020 Sep; 9(18):6646-6657. PubMed ID: 32750229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer.
    de Vos II; Meertens A; Hogenhout R; Remmers S; Roobol MJ;
    Eur Urol; 2023 Oct; 84(4):426-434. PubMed ID: 37029074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.
    He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X
    Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
    Machiela MJ; Lindström S; Allen NE; Haiman CA; Albanes D; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock S; Gaziano JM; Gapstur SM; Giovannucci E; Henderson BE; Jacobs EJ; Kolonel LN; Krogh V; Ma J; Stampfer MJ; Stevens VL; Stram DO; Tjønneland A; Travis R; Willett WC; Hunter DJ; Le Marchand L; Kraft P
    Am J Epidemiol; 2012 Dec; 176(12):1121-9. PubMed ID: 23193118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
    Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
    Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
    Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Grönberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw KT; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum KU; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM;
    BMJ; 2018 Jan; 360():j5757. PubMed ID: 29321194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
    Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
    PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.
    Li W; Middha M; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Häggström C; Hallmans G; Rönn AC; Stattin P; Melander O; Ulmert D; Lilja H; Klein RJ
    Eur Urol; 2018 Dec; 74(6):710-719. PubMed ID: 30289108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
    Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
    Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ.
    Menezes RDS; Dornas MC; Campos CFF; Rodeiro DB; Carrerette FB; Oliveira RV; de Souza BA; Alves de Souza Carvalho G; Brito IAA; Silva DA; Damião R; Porto LC
    Prostate; 2024 Feb; 84(2):166-176. PubMed ID: 37839045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality.
    Zelic R; Fiano V; Ebot EM; Coseo Markt S; Grasso C; Trevisan M; De Marco L; Delsedime L; Zugna D; Mucci LA; Richiardi L
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):284-291. PubMed ID: 30341411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replication of prostate cancer risk loci in a Japanese case-control association study.
    Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
    J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
    Na R; Zheng SL; Han M; Yu H; Jiang D; Shah S; Ewing CM; Zhang L; Novakovic K; Petkewicz J; Gulukota K; Helseth DL; Quinn M; Humphries E; Wiley KE; Isaacs SD; Wu Y; Liu X; Zhang N; Wang CH; Khandekar J; Hulick PJ; Shevrin DH; Cooney KA; Shen Z; Partin AW; Carter HB; Carducci MA; Eisenberger MA; Denmeade SR; McGuire M; Walsh PC; Helfand BT; Brendler CB; Ding Q; Xu J; Isaacs WB
    Eur Urol; 2017 May; 71(5):740-747. PubMed ID: 27989354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
    Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
    Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
    Lin HY; Huang PY; Cheng CH; Tung HY; Fang Z; Berglund AE; Chen A; French-Kwawu J; Harris D; Pow-Sang J; Yamoah K; Cleveland JL; Awasthi S; Rounbehler RJ; Gerke T; Dhillon J; Eeles R; Kote-Jarai Z; Muir K; ; Schleutker J; Pashayan N; ; Neal DE; Nielsen SF; Nordestgaard BG; Gronberg H; Wiklund F; Giles GG; Haiman CA; Travis RC; Stanford JL; Kibel AS; Cybulski C; Khaw KT; Maier C; Thibodeau SN; Teixeira MR; Cannon-Albright L; Brenner H; Kaneva R; Pandha H; ; Srinivasan S; Clements J; Batra J; Park JY
    Sci Rep; 2021 Apr; 11(1):9264. PubMed ID: 33927218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.